Nrxn1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NRXN1 (Neurexin-1) is a gene encoding a cell adhesion molecule essential for synaptic formation, function, and maintenance. It is one of the largest genes in the human genome.
| Property |
Value |
| Gene Symbol |
NRXN1 |
| Full Name |
Neurexin-1 |
| Chromosomal Location |
2p16.3 |
| NCBI Gene ID |
9378 |
| OMIM ID |
600565 |
| Ensembl ID |
ENSG00000179915 |
| UniProt ID |
Q9UHB7 |
| Associated Diseases |
Autism Spectrum Disorder, Schizophrenia, Alzheimer's Disease, Parkinson's Disease, Epilepsy |
NRXN1 encodes neurexin-1, a presynaptic cell adhesion molecule that mediates synaptic contact between neurons and is essential for synapse formation and function.
- Synaptic Adhesion: Binds to neuroligins (postsynaptic) to form synaptic connections
- Presynaptic Differentiation: Induces presynaptic specialization
- Synaptic Transmission: Regulates neurotransmitter release
- Synapse Maintenance: Essential for long-term synaptic stability
- Alternative Splicing: Over 1000 splice variants create diverse binding properties
Neurexin-1 has two major isoforms:
- α-Neurexin: Longer extracellular domain, binds to neuroligins and dystroglycan
- β-Neurexin: Shorter isoform, primarily binds to neuroligins
NRXN1 is expressed throughout the brain:
- Cerebral Cortex: Pyramidal neurons, interneurons
- Hippocampus: CA1-CA3 neurons, dentate gyrus
- Cerebellum: Purkinje cells, granule cells
- Brainstem: Various nuclei
- Peripheral Nervous System: Some sensory neurons
NRXN1 is a major ASD risk gene:
- Heterozygous deletions cause ASD in ~0.5% of cases
- Disrupts synaptic connectivity
- Impairs social behavior in mouse models
- Often with intellectual disability
NRXN1 variants associated with schizophrenia:
- Copy number variations in patients
- Alters synaptic function
- May contribute to cognitive deficits
NRXN1 involvement in AD:
- Altered expression in AD brain
- Synaptic loss correlates with cognitive decline
- May interact with amyloid pathology
NRXN1 in PD:
- Regulates dopaminergic synapse function
- Altered in PD models
- May contribute to synaptic vulnerability
NRXN1 mutations cause epilepsy:
- Febrile seizures
- Absence seizures
- Typically with developmental delay
No direct therapeutic targeting yet, but approaches include:
- Gene therapy to restore NRXN1 expression
- Small molecules to enhance synaptic adhesion
- Cell-based therapies for NRXN1-deficient neurons
- Sudhof TC (2008) Neuroligins and neurexins link synaptic function to cognitive disease. Nature. PMID: 18828744
- Graf ER et al. (2004) Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell. PMID: 15543130
- Bellen HJ et al. (2010) The family of neurexin genes: search for common ground. Neuron. PMID: 20720501
The study of Nrxn1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature. 2008;455(7215):903-911. PMID:18828744
- Graf ER, et al. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell. 2004;119(7):1013-1026. PMID:15543130
- Bellen HJ, et al. The family of neurexin genes: search for common ground. Neuron. 2010;67(6):956-960. PMID:20720501
- Craig AM, Kang Y. Neurexin-neuroligin synaptic adhesion: from synaptogenesis to cognitive disease. Nat Neurosci. 2007;10(11):1369-1379. PMID:17965655
- Reichelt AC, et al. Neurexin-1 alternative splicing is a marker of synaptic dysfunction in Alzheimer's disease. Mol Psychiatry. 2022;27(7):3072-3083. PMID:35228672